Neuronetics, Inc. (NASDAQ: STIM) has shared its preliminary fourth quarter and full-year revenue figures for 2024, alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results